Oridermyl: The Dosage Of Triamcinolone Acetonide May Be Out Of Specification For The Affected Lots.
Oridermyl oral paste is being recalled in Canada because certain batches may contain incorrect amounts of the active ingredient triamcinolone acetonide. This is a Class I recall, which indicates a serious safety issue. The affected product was distributed across Canada.
- Product
- Oridermyl
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-11-28
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/0299d5a8-ddb7-4b57-8a5c-b194489be401